GTBP vs. VOO

In the year-to-date period, GTBP achieves a -11.48% return, which is significantly lower than VOO's 1.00% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for GT Biopharma, Inc. (GTBP) and Vanguard S&P 500 ETF (VOO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current GTBP Sharpe Ratio is -0.23, which is lower than the VOO Sharpe Ratio of 0.70. The chart below compares the historical Sharpe Ratios of GTBP and VOO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

GTBP has not paid dividends to shareholders, while VOO's dividend yield for the trailing twelve months is around 1.29%.

The maximum GTBP drawdown since its inception was -99.95%, which is greater than VOO's maximum drawdown of -33.99%. Use the drawdown chart below to compare losses from any high point for GTBP and VOO.

GT Biopharma, Inc. (GTBP) has a higher volatility of 25.81% compared to Vanguard S&P 500 ETF (VOO) at 4.83%. This indicates that GTBP's price experiences larger fluctuations and is considered to be riskier than VOO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.